Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Prospective, Open Label, Multicenter Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping

NCT02209532 is registered in ClinicalTrials.gov with Novadaq Technologies ULC, now a part of Stryker as lead sponsor.

NCT NCT02209532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02209532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Prospective, Open Label, Multicenter Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping
Lead sponsor
Novadaq Technologies ULC, now a part of Stryker
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2015
Completion date
June 30, 2017
Enrollment
180 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, uterine cancer